SCHEMBL30727809

SCHEMBL30727809

CNC(=O)c1ccc(C#CC(F)(F)F)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
ACACB O00763 1/20 0.47
HTT P42858 2/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PLK1 P53350 7/20 0.45
GRM5 P41594 1/20 0.43
LMNA P02545 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HDAC4 P56524 1/20 0.42
CA2 P00918 1/20 0.42
MMP13 P45452 1/20 0.41
RARB P10826 1/20 0.41
RARG P13631 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16198925 0.83 HDAC2 (0.61) HDAC6HDAC2HDAC8ACACBHTT
SCHEMBL28610694 0.80 ACACB (0.43) HDAC6ACACBHPGDSMN1; SMN2LMNA
SCHEMBL4491505 0.79 PTPN11 (0.53) HTTHPGDTSHRLMNAL3MBTL1
SCHEMBL25558979 0.79 ACACB (0.52) HDAC6HDAC2HDAC8ACACBHTT
SCHEMBL18472972 0.78 HDAC2 (0.55) HDAC6HDAC2HDAC8ACACBHTT
SCHEMBL4491026 0.78 RARB (0.55) ACACBHPGDTSHRSMN1; SMN2CA2
SCHEMBL24230200 0.77 MMP13 (0.62) HDAC6HDAC2HDAC8ACACBHTT
SCHEMBL29877145 0.77 PARP10 (0.43) TSHRGRM5L3MBTL1CA2RARB
SCHEMBL22741083 0.75 HTT (0.38) HTTLMNAL3MBTL1RARBRARG
SCHEMBL250247 0.74 HDAC6 (0.80) HDAC6HDAC2HDAC8HTTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4551578-A1 MACROCYCLIC INHIBITORS OF KRAS FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2025-05-14 EP claimed
WO-2024008610-A1 MACROCYCLIC INHIBITORS OF KRAS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2024-01-11 WO claimed
EP-4551578-A1 MACROCYCLIC INHIBITORS OF KRAS FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2025-05-14 EP disclosed
WO-2024008610-A1 MACROCYCLIC INHIBITORS OF KRAS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2024-01-11 WO disclosed